Skip to main content
SpringerLink
Log in

Debunking dogma: Surgery for four or more colorectal liver metastases is justified

  • Published:
Journal of Gastrointestinal Surgery Aims and scope

Abstract

Treatment of four or more colorectal liver metastases (CRLMs) is controversial and remains a relative contraindication to surgery at some institutions. We sought to assess the outcome of patients with four or more CRLMs treated with surgery. Patients (159) with four or more CRLMs were treated surgically at a single institution. The median number of treated lesions was 5 (range, 4–14). The majority of patients received neoadjuvant chemotherapy (89.9%). Forty-six (29.0%) patients underwent resection only, 12 (7.5%) underwent radiofrequency ablation (RFA) only, and 101 (63.5%) underwent resection plus RFA. The 5-year actuarial disease-free and overall survival rates were 21.5% and 50.9%, respectively. Patients who underwent RFA as part of their surgical procedure (hazard ratio [HR] =1.81, P =0.03) and those with a positive surgical resection margin (HR=1.52, P =0.01) were more likely to have a shorter time to recurrence. Patients who did not have a reduction in tumor size following neoadjuvant chemotherapy had a higher likelihood of death following surgical treatment (HR=2.53, P =0.01). Patients with four or more CRLMs should be considered for aggressive surgical treatment, including liver resection with or without RFA, in order to improve the chance of long-term survival. Certain clinicopathologic factors, including lack of response to neoadjuvant chemotherapy, were associated with a worse prognosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Scheele J, Stang R, Altendorf-Hofmann A, et al. Resection of colorectal liver metastases. World J Surg 1995;19:59–71.

    Article  PubMed  CAS  Google Scholar 

  2. Adson MA, van Heerden JA, Adson MH, et al. Resection of hepatic metastases from colorectal cancer. Arch Surg 1984; 119:647–651.

    PubMed  CAS  Google Scholar 

  3. Hughes KS, Rosenstein RB, Songhorabodi S, et al. Resection of the liver for colorectal carcinoma metastases. A multi-institutional study of long-term survivors. Dis Colon Rectum 1988;31:1–4.

    Article  PubMed  CAS  Google Scholar 

  4. Adam R, Avisar E, Ariche A, et al. Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal. Ann Surg Oncol 2001;8:347–353.

    Article  PubMed  CAS  Google Scholar 

  5. Choti MA, Sitzmann JV, Tiburi MF, et al. Trends in longterm survival following liver resection for hepatic colorectal metastases. Ann Surg 2002;235:759–766.

    Article  PubMed  Google Scholar 

  6. Abdalla EK, Vauthey JN, Ellis LM, et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 2004;239:818–825; discussion 825–817.

    Article  PubMed  Google Scholar 

  7. Nordlinger B, Guiguet M, Vaillant JC, et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. Cancer 1996;77:1254–1262.

    Article  PubMed  CAS  Google Scholar 

  8. Fong Y, Fortner J, Sun RL, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999;230:309–318.

    Article  PubMed  CAS  Google Scholar 

  9. Rosen CB, Nagorney DM, Taswell HF, et al. Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma. Ann Surg 1992; 216:493–504; discussion 504-495.

    Article  PubMed  CAS  Google Scholar 

  10. Hughes KS, Simon R, Songhorabodi S, et al. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence. Surgery 1986;100:278–284.

    PubMed  CAS  Google Scholar 

  11. Ekberg H, Tranberg KG, Andersson R, et al. Determinants of survival in liver resection for colorectal secondaries. Br J Surg 1986;73:727–731.

    Article  PubMed  CAS  Google Scholar 

  12. Gayowski TJ, Iwatsuki S, Madariaga JR, et al. Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery 1994; 116:703–710; discussion 710-701.

    PubMed  CAS  Google Scholar 

  13. BoltonJS, Fuhrman GM. Survival after resection of multiple bilobar hepatic metastases from colorectal carcinoma. Ann Surg 2000;231:743–751.

    Article  PubMed  CAS  Google Scholar 

  14. Kokudo N, Miki Y, Sugai S, et al. Genetic and histological assessment of surgical margins in resected liver metastases from colorectal carcinoma: minimum surgical margins for successful resection. Arch Surg 2002;137:833–840.

    Article  PubMed  Google Scholar 

  15. Minagawa M, Makuuchi M, Torzilli G, et al. Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results. Ann Surg 2000;231:487–499.

    Article  PubMed  CAS  Google Scholar 

  16. Jamison RL, Donohue JH, Nagorney DM, et al. Hepatic resection for metastatic colorectal cancer results in cure for some patients. Arch Surg 1997;132:505–510; discussion 511.

    PubMed  CAS  Google Scholar 

  17. Ercolani G, Grazi GL, Ravaioli M, et al. Liver resection for multiple colorectal metastases: influence of parenchymal involvement and total tumor volume, vs number or location, on long-term survival. Arch Surg 2002;137:1 187–1192.

    Google Scholar 

  18. Weber SM, Jarnagin WR, DeMatteo RP, et al. Survival after resection of multiple hepatic colorectal metastases. Ann Surg Oncol 2000;7:643–650.

    Article  PubMed  CAS  Google Scholar 

  19. Kokudo N, Imamura H, Sugawara Y, et al. Surgery for multiple hepatic colorectal metastases. J Hepatobiliary Pancreat Surg 2004;11:84–91.

    Article  PubMed  Google Scholar 

  20. Strasberg SM. The Brisbane 2000 terminology of liver anatomy and resection. HPB 2000;2:333–339.

    Google Scholar 

  21. Pearson AS, Izzo F, Fleming RY, et al. Intraoperative radiofrequency ablation or cryoablation for hepatic malignancies. AmJ Surg 1999;178:592–599.

    Article  CAS  Google Scholar 

  22. Curley SA, Izzo F, Ellis LM, et al. Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg 2000;232:381–391.

    Article  PubMed  CAS  Google Scholar 

  23. Pawlik TM, Izzo F, Cohen DS, et al. Combined resection and radiofrequency ablation for advanced hepatic malignancies: results in 172 patients. Ann Surg Oncol 2003;10:1059–1069.

    Article  PubMed  Google Scholar 

  24. Kato T, Yasui K, Hirai T, et al. Therapeutic results for hepatic metastasis of colorectal cancer with special reference to effectiveness of hepatectomy: analysis of prognostic factors for 763 cases recorded at 18 institutions. Dis Colon Rectum 2003;46:S22-S31.

    PubMed  Google Scholar 

  25. Nordlinger B, Quilichini MA, Parc R, et al. Hepatic resection for colorectal liver metastases. Influence on survival of preoperative factors and surgery for recurrences in 80 patients. Ann Surg 1987;205:256–263.

    Article  PubMed  CAS  Google Scholar 

  26. Doci R, Bignami P, Montalto F, et al. Prognostic factors for survival and disease-free survival in hepatic metastases from colorectal cancer treated by resection. Tumori 1995;81:143–146.

    PubMed  CAS  Google Scholar 

  27. Adam R, Pascal G, Castaing D, et al. Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases? Ann Surg 2004;240:1052–106; discussion 1061–1054.

    Article  PubMed  Google Scholar 

  28. Curley SA, Izzo F, Delrio P, et al. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients. Ann Surg 1999;230:1–8.

    Article  PubMed  CAS  Google Scholar 

  29. Wood TF, Rose DM, Chung M, et al. Radiofrequency ablation of 231 unresectable hepatic tumors: indications, limitations, and complications. Ann Surg Oncol 2000;7:593–600.

    PubMed  CAS  Google Scholar 

  30. de Baere T, Elias D, Dromain C, et al. Radiofrequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 year. AJR Am J Roentgenol 2000;175:1619–1625.

    PubMed  Google Scholar 

  31. Bilchik AJ, Wood TF, Allegra DP. Radiofrequency ablation of unresectable hepatic malignancies: lessons learned. Oncologist 2001;6:24–33.

    Article  PubMed  CAS  Google Scholar 

  32. Cady B, Stone MD, McDermott WVJr, et al. Technical and biological factors in disease-free survival after hepatic resection for colorectal cancer metastases. Arch Surg 1992;127:561–568; discussion 568-569.

    PubMed  CAS  Google Scholar 

  33. Doci R, Gennari L, Bignami P, et al. One hundred patients with hepatic metastases from colorectal cancer treated by resection: analysis of prognostic determinants. Br J Surg 1991;78:797–801.

    Article  PubMed  CAS  Google Scholar 

  34. Levi F, Zidani R, Brienza S, et al. A multicenter evaluation of intensified, ambulatory, chronomodulated chemotherapy with oxaliplatin, 5-fluorouracil, and leucovorin as initial treatment of patients with metastatic colorectal carcinoma. International Organization for Cancer Chronotherapy. Cancer 1999;85:2532–2540.

    Article  PubMed  CAS  Google Scholar 

  35. Douillard JY, Cunningham D, Roth AD, et al. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet 2000;355:1041–1047.

    Article  PubMed  CAS  Google Scholar 

  36. Giacchetti S, Perpoint B, Zidani R, et al. Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer. J Clin Oncol 2000;18:136–147.

    PubMed  CAS  Google Scholar 

  37. de Gramont A, Figer A, Seymour M, et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 2000;18:2938–2947.

    PubMed  Google Scholar 

  38. Rougier P, Van Cutsem E, Bajetta E, et al. Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer. Lancet 1998;352:1407–1412.

    Article  PubMed  CAS  Google Scholar 

  39. Bismuth H, Adam R, Levi F, et al. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 1996;224:509–520; discussion 520-502.

    Article  PubMed  CAS  Google Scholar 

  40. Tanaka K, Adam R, Shimada H, et al. Role of neoadjuvant chemotherapy in the treatment of multiple colorectal metastases to the liver. Br J Surg 2003;90:963–969.

    Article  PubMed  CAS  Google Scholar 

  41. Allen PJ, Kemeny N, Jarnagin W, et al. Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases. J Gastrointest Surg 2003;7:109–115; discussion 116-107.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgical Oncology, Unit 444, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 444, P.O. Box 301402, 77030, Houston, TX

    Timothy M. Pawlik M.D., M.P.H., Eddie K. Abdalla M.D., Lee M. Ellis M.D., Jean-Nicolas Vauthey M.D. & Steven A. Curley M.D.

Authors
  1. Timothy M. Pawlik M.D., M.P.H.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eddie K. Abdalla M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lee M. Ellis M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jean-Nicolas Vauthey M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Steven A. Curley M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Steven A. Curley M.D..

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pawlik, T.M., Abdalla, E.K., Ellis, L.M. et al. Debunking dogma: Surgery for four or more colorectal liver metastases is justified. J Gastrointest Surg 10, 240–248 (2006). https://doi.org/10.1016/j.gassur.2005.07.027

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1016/j.gassur.2005.07.027

Key words

Search

Navigation